446 results about "Diketone" patented technology

The invention relates to the technical field of scintillator materials and X-ray detection, in particular to a rare earth organic-inorganic hybrid complex scintillator and a preparation method and application thereof. The general formula of the rare earth organic-inorganic hybrid complex scintillator is [RE (L) 4] <->. [A] < + >, wherein RE is selected from Eu, Tb, Sm or Dy; l is a beta-diketone ligand; [A] < + > is selected from long-chain hydrophobic quaternary ammonium salt cations or heterocyclic quaternary ammonium cations which have the carbon atom number of C8-C20 and do not contain active functional groups. The rare earth organic-inorganic hybrid complex scintillator provided by the invention has good solubility and molecular-level dispersion capability. The scintillator film based on the rare earth organic-inorganic hybrid complex prepared by using the rare earth organic-inorganic hybrid complex has the characteristic of compatibility of high scintillator load and high light transmission, overcomes the problems of low scintillator load rate, poor transparency and limited imaging resolution of the traditional scintillator film, and has excellent practical value and popularization prospect.

The invention discloses a preparation method of 5-hydroxy-3-iminopyridine-2, 6-diketone, and relates to the technical field of compound preparation. The invention provides a preparation method of 5-hydroxy-3-iminopyridine-2, 6-diketone, which comprises the following steps: uniformly mixing observation blue with at least one oxidant of sodium hypochlorite, potassium permanganate and hydrogen peroxide according to a molar ratio of 1: (0.5-1.5) under a solution condition, reacting for 5-120 minutes, and adding a reducing agent to finish the reaction, thereby obtaining a target product. According to the preparation method provided by the invention, on the basis of the amide structure of the ornamental blue, 'endogenous catalysis' of the reaction can be realized, no additional catalyst needs to be introduced, and the 5-hydroxy-3-iminopyridine-2, 6-diketone with the yield of more than 60.53% and the purity of more than 60.2% can be prepared through a simple and convenient one-step reaction.

The present invention provides a production method of a thienopyrimidine derivative or a salt thereof which has a gonadotropin releasing hormone (GnRH) antagonistic action with high quality in high yield. The present invention provides a method of producing a thienopyrimidine derivative, which comprises reacting 6-(4-aminophenyl)-1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl) thieno[2,3-d]pyrimidine-2,4 (1H,3H)-dione or salt thereof, 1,1′-carbonyldiimidazole or a salt thereof and methoxyamine or a salt thereof, and the like.

The invention relates to the technical field of organic photoelectric materials, and particularly discloses a non-condensed ring small molecule acceptor material based on a quinonoid structure as well as a preparation method and application of the non-condensed ring small molecule acceptor material. According to the invention, easily available 1, 4-diacetyl piperazine-2, 5-diketone is used as a center, an alkyl chain and Ar are used for modification, EG is used as an end group, the non-condensed ring A-D-A '-D-A type structure acceptor material based on a quinone structure is constructed, and the general formula is shown in the specification. Wherein the PCE of the acceptor material which is modified by bithiophene and takes 2-(3-ethyl-4-oxothiazolidine-2-subunit) malononitrile as a terminal group reaches 15%. The non-condensed ring small molecule acceptor material based on the quinonoid structure is simple in synthesis process, and an effective strategy is provided for solving the problem of the overall performance of an organic solar cell.

The present invention provides triazinedione derivatives, their preparation methods, and their pharmaceutical applications. Specifically, the present invention provides triazinedione derivatives represented by general formula (I), their preparation methods, pharmaceutical compositions containing said derivatives, and uses thereof as therapeutic agents, particularly their use in the preparation of myosin inhibitors and in the preparation of drugs for treating hypertrophic cardiomyopathy (HCM) or cardiac diseases with pathophysiological characteristics associated with HCM. JPEG2023550444000158.jpg50170

The invention provides a liquid sulfur removal agent and a preparation method thereof, and belongs to the technical field of natural gas hydrogen sulfide removal treatment.The liquid sulfur removal agent comprises, by weight, 36-66% of s-triazine derivatives, 5-8% of sulfolane, 2-5% of a pH control agent, 10-12% of a stabilizer, 5-8% of a scale inhibitor, 1-2% of a bactericide and the balance deionized water; wherein the s-triazine derivative is selected from a mixture of hexahydro-1, 3, 5-triacetyl-hexahydros-triazine, 1, 3, 5-triacetyl-hexahydros-triazine and 1, 3, 5-triazinane-2, 4-diketone, and the structural formula of the s-triazine derivative is shown in the description. The liquid sulfur removal agent is high in sulfur removal efficiency, good in corrosion inhibition and sterilization performance and not prone to scaling.

The invention provides a diketone biphenyl compound serving as a VAV1 degradation agent and application of the diketone biphenyl compound. Specifically provided are a compound represented by formula (I), a tautomer, a stereoisomer, a pharmaceutically acceptable salt or a prodrug thereof. The compound provided by the invention is good in drug effect and can be used for preparing drugs for treating or preventing VAV1 related diseases.

The invention belongs to the technical field of biological engineering, and provides curcumin / dihydrocurcumin reductase MaCurA, a coding gene and application. The reductase can efficiently catalyze 1, 7-bis (4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3, 5-diketone to synthesize tetrahydrocurcumin, an efficient solution is provided for industrial preparation of tetrahydrocurcumin, and experiments prove that the recombinase can catalyze the synthesis of tetrahydrocurcumin in the catalysis of 1, 7-bis (4-hydroxy-3-methoxyphenyl)-1, 6-heptadiene-3, 5-diketone. In a reaction system for preparing tetrahydrocurcumin from 2, 5-diketone, actually measured enzyme activity is stabilized at 3.38 U / mg level, and compared with a traditional chemical synthesis method, the production efficiency is remarkably improved.

The invention relates to a piperidinedione compound as well as a pharmaceutical composition and application thereof, and particularly provides a piperidinedione compound shown in a formula (I) which can be used for preparing medicines, especially medicines for preventing and / or treating diseases or symptoms caused by or related to lymphocyte development or activity disorder. Each group in the formula (I) is as defined in the specification.

The invention relates to the technical field of pharmaceutical chemicals, in particular to a preparation method of 11beta, 17alpha-dyhydroxyl-6 alpha-methylpregna-4-ene-3, 20-diketone, and discloses a preparation method of 11beta, 17alpha-dyhydroxyl-6 alpha-methylpregna-4-ene-3, 20-diketone. The method comprises the following steps: S1, adding a 11beta, 17alpha-dyhydroxyl-6 alpha-methylpregna-4-ene-3, 20-diketone crude product into a mixed solution of a solvent A and a solvent B, heating to 25-35 DEG C, and stirring for dissolving until the solution is clear, so as to obtain a 11beta, 17alpha-dyhydroxyl-6 alpha-methylpregna-4-ene-3, 20-diketone crude product; s2, carrying out transposition elimination reaction; s3, carrying out acidification deprotection reaction; s4, adjusting the pH value; s5, standing and layering; s6, decoloring; s7, performing concentration; s8, cooling and crystallizing; s9, carrying out solid-liquid separation; and S10, carrying out vacuum drying, so as to obtain a finished product of the 11beta, 17alpha-dyhydroxyl-6 alpha-methyl pregna-4-ene-3, 20-diketone. The method has the characteristics of high yield and good product quality, is stable and is easy to realize industrial production.

The invention discloses a 3-aryl piperidine-2, 6-diketone compound as shown in a general formula I or an enantiomer, a diastereoisomer, a raceme and a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the 3-aryl piperidine-2, 6-diketone compound, the compound is used as a VAV1 targeted molecular glue degradation agent, and can degrade VAV1 protein in a targeted manner, so that the VAV1 protein can be degraded in a targeted manner. The invention has the application of preparing medicines for treating and / or preventing inflammatory diseases and autoimmune diseases.

The present invention discloses a series of fused polycyclic substituted 5-carboxylic acid thienopyrimidinedione compounds and their uses, specifically, those of formula (II): The compound represented by TIFF2024507408000065.tif5475 and pharma- ceutically acceptable salts thereof are disclosed.

The invention discloses an anthraquinone compound with anti-MTV activity and a preparation method and application thereof.The anthraquinone compound with the anti-MTV activity is prepared from stems and leaves of desmodium caudatum through the steps of pretreatment, extract extraction, silica gel column chromatography and separation and purification, the molecular formula of the anthraquinone compound with the anti-MTV activity is C18H17O7, and the structural formula of the anthraquinone compound with the anti-MTV activity is shown in the description. The preparation method comprises the following steps: 1, 6-dihydroxy-2, 7, 8-trimethoxy-3-methyl anthracene-9, 10-diketone is used as a raw material, and is named as 1, 6-dihydroxy-2, 7, 8-trimethoxy-3-methyl According to the invention, the English name is 1, 6-dihydroxy-2, 7, 8-trimesoxy-3-methylanthracene-9, 10-dione, and the English name is 1, 6-dihydroxy-2, 7, 8-trimesoxy-3-methylanthracene-9, 10-dione. The present invention has the following structure. Activity tests show that the compound has a certain inhibition effect on MTV. The novel compound disclosed by the invention is novel in structure, has certain anti-MTV activity, can be used as an anti-MTV lead compound, and can be used for research and development of anti-MTV prevention and treatment drugs.

The invention provides a purification method of a naphthalimide high-purity electronic-grade photoacid generator. The method solves the problem that photo-acid cannot be purified by traditional recrystallization or directly through ion exchange columns and other methods. The method comprises the following steps: firstly synthesizing and preparing 1, 3-diketone-2-hydroxy-6-(1-hexyne) benzisoquinoline, then reacting with triethylamine and trifluoromethylsulfonyl chloride to generate a crude product 1, 3-diketone-2-(1, 1, 1-trifluoromethyl) methanesulfonic ester-6-(1-hexyne) benzisoquinoline, removing impurities from normal hexane to obtain a pure product, sublimating the material into a gas phase by using a quartz vacuum sublimation instrument, and purifying to obtain the 1, 3-diketone-2-(1, 1, 1-trifluoromethyl) methanesulfonic ester-6-(1-hexyne) benzisoquinoline. And then passing through Pure MTS9500 amino phosphonic acid type chelating resin, and finally cooling in a quartz tube to obtain the high-purity electronic-grade photoacid generator. According to the invention, the stability is high, the metal ion content is low, the purification process is convenient to process, the product is used as a photoresist-level core main material, the product is widely applied in the fields of semiconductor photoresist, other imaging systems, photocureable coatings and the like, the market scale is continuously expanded, and the product is an indispensable key material in semiconductor manufacturing and other related fields.

The invention specifically discloses a beta-diketone iridium complex as well as a preparation method and application thereof, and relates to the technical field of biological medicines. The beta-diketone iridium complex provided by the invention has high phototoxicity and low dark toxicity, can be applied to tumor cells as effective PSs of PDT, and is specifically delivered to the tumor cells by taking a traditional Chinese medicine monomer tripterine as a supplement in combination with a nano-targeting delivery technology for photodynamic / immune synergistic treatment of hypoxic tumors.

The present disclosure provides a compound of Formula (I'): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein Rx, X1, X2, and Ri are as defined herein, and methods of making and using same.

The present application relates to a kind of nanodroplet system based on interface crosslinking curcumin and its preparation method, by the crosslinking complexation between gallic acid ester, metal ion, curcumin to construct nanodroplet system.Gallic acid ester is polyphenol compound, contains a large number of phenolic hydroxyl in structure, has strong chelating metal ability, can be complexed with most of trivalent metal ions and divalent excessive metal ions, called metal phenolic network;Metal ions such as copper, iron and other metal ions form complex by electrostatic interaction with the beta diketone group in the structure of curcumin.Therefore, the nanodroplet system constructed by the present application can maintain the chemical stability and light stability of curcumin, and has wide prospect for improving the current food field curcumin low solubility, poor stability and other problems.

The present disclosure relates to dihydropyrimidine-2,4(1H,3H)-dione-containing polycyclic compounds, or pharmaceutically acceptable salts thereof, and compositions thereof which are effective to reduce or modulate widely interspaced zinc finger motifs (WIZ) protein expression levels and / or induce fetal hemoglobin (HbF) expression, and also relates to methods of their preparation and their use in treatment of subjects in need.

The invention provides new pyrazine derivatives of formula (I): (I) or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein. The invention also provides pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Disclosed are a semiconductor photoresist composition and a method of forming patterns using the same, the semiconductor photoresist composition including an organometallic compound; a cyclic diketone compound; and a solvent.

The present invention described herein relates to a compound having Structure I for treating diseases and disorders for which inhibition or modulation of the Ubiquitin Ligase COP1 enzyme produces a physiologically beneficial response, in particular for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). These compounds having Structure I are capable of increasing the level of adipose triglyceride lipase (ATGL). Also provided is the process of preparing compounds having Structure I.

The invention discloses a diketopiperazine heterodimer as well as a biosynthesis method and application thereof, and belongs to the technical field of bioengineering. The biosynthesis method of the diketopiperazine heterodimer comprises the following steps: S1, culturing a recombinant cell containing P450 dimerization enzyme or a mutant thereof, and performing induced expression to obtain a whole-cell culture; and S2, adding a cyclic dipeptide substrate containing tryptophan into the whole-cell culture, carrying out a catalytic reaction, and separating and purifying the obtained product to obtain the diketopiperazine heterodimer. According to the invention, the P450 dimerization enzyme or the mutant thereof is used for catalyzing the biosynthesis of the tryptophan-containing diketopiperazine into the diketopiperazine heterodimer with different regioselectivity / stereoselectivity, the biosynthesis method is green and environment-friendly, the efficiency is high, and the variety of the diketopiperazine heterodimer is greatly expanded.

The embodiment of the invention discloses a plastic filling lubricating master batch and a preparation method thereof. The plastic filling lubricating master batch comprises a filling agent, a polypropylene material, a heat stabilizer, an antioxidant, a reaction accelerator, a modifier, an elastic material, a lubricant and a coupling agent, wherein the filling agent is calcium carbonate; the polypropylene material is polypropylene 7042; the heat stabilizer is compounded by zinc stearate and a beta-diketone auxiliary stabilizer; the antioxidant comprises a main antioxidant, an auxiliary antioxidant and a synergist; the reaction accelerant is a compound of stearic acid and citric acid; the modifier is PE wax and / or EBS; the elastic material is POE (Polyolefin Elastomer); the lubricant is prepared by compounding erucyl amide and modified polyethylene wax; the coupling agent is a titanate coupling agent.

The present invention relates to an unsymmetrical squaraine dye of formula (I) and process for the preparation thereof. The process includes dissolving a 3-cycloalkene-1,2-dione compound in acetone and aqueous HCl to afford a semisquaraine compound. The process includes refluxing the semisquaraine compound and phenyl carboxylic acid dissolved in solvent to afford the unsymmetrical squaraine dye. Further, the present invention relates to an electronic device with an enhanced device efficiency containing a dye of formula (I) co-sensitized with a squaraine dye.

The present application relates to a kind of from androsta 1, 4-diene-3, 17-dione starting synthesis of estren and the method of a kind of compound thereof.Especially, the present application provides a kind of preparation method of estren shown in formula I, comprising the following steps: in inert solvent, androsta-1, 4-diene-3, 17-dione (II) with reagent R4VX carries out demethylation aromatization reaction step directly to obtain estren (I);Wherein, the definition of reaction substrate, reagent and reaction condition is as claimed in claim or specification.The method is simple in operation, and good in selectivity, and product purity is high, suitable for industrial production.

The invention relates to the related technical field of organic synthesis, in particular to a preparation method of an aldehyde compound, an ortho-diketone compound and a hydroxyquinolinone derivative, which comprises the following steps: firstly, mixing a benzoyl methyl substituted triazole compound, water and a Fecatalyst in an oxygen atmosphere, and reacting under a heating condition; and then carrying out post-treatment on the reaction system to obtain the aldehyde compound, the o-diketone compound or the hydroxyquinolinone derivative. By introducing the Fecatalyst, the oxidation process of benzoylmethyl substituted triazole can be effectively catalyzed, so that the functionalization of triazole molecules is realized. The synthesis method is mild in reaction condition, simple and convenient to operate, high in product yield and low in cost, and has a good application prospect and popularization value.

The application discloses application of a pyrimidinotriazine diketone derivative in preparation of a medicine for inhibiting activity of human protease caspase-1, and belongs to the technical field of medicines. In view of defects of existing caspase-1 inhibitors, the compound has the characteristics of high affinity binding to caspase-1 (K D = 8.11 μM; 8.78 μM) and strong inhibition on the activity (IC 50 = 11.90 nM-14.47 nM). The compound is used for preparation of a medicine for inhibiting the activity of caspase-1 and a medicine for treating inflammation-related diseases such as sepsis-related lung injury, acute respiratory distress syndrome or acute pancreatitis.

The present application relates to a kind of conjugated microporous polymer, film and its preparation and application, the present application is respectively introduced 1,3,5-tri (4-aminophenyl) benzene, 2,4,6-tri (4-aminophenyl) -1,3,5-triazine or tri (4-aminophenyl) amine on the basis of 3,4-dihydroxy-3-cyclobutene-1,2-diketone, powder polymer is prepared, then through electroblasting technology obtains conjugated microporous polymer film.The conjugated microporous polymer film prepared by the present application realizes the detection of NO2 at room temperature, its preparation method is green and simple, low in price, overcomes the problem that conjugated microporous polymer is difficult to process, has good sensing application prospect.

This application discloses a phenanthroline benzimidazole-structured polyimide single rare-earth ion coordination full-spectrum luminescent material, its preparation method, and its applications, belonging to the field of polymer luminescent material preparation technology. This phenanthroline benzimidazole-structured polyimide single rare-earth ion coordination full-spectrum luminescent material comprises a phenanthroline benzimidazole-structured polyimide, a rare-earth ion, and a β-diketone-structured small organic molecule ligand bound through coordination. This polymer single rare-earth coordination material retains the advantages of polyimide while exhibiting the characteristics of rare-earth ions (Ln... 3+ The addition of ) brings special optical properties, coordination polymers and rare earth ions Tb 3+ PI-Tb formed after coordination 3+ It can emit full-spectrum white light (CIE = (0.31, 0.35)) and exhibits excellent thermal stability and solubility.